Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation DOI Creative Commons
Cuiying Liu, Jiayi Guo, Longfei Guan

et al.

Stroke and Vascular Neurology, Journal Year: 2025, Volume and Issue: unknown, P. svn - 003442

Published: Feb. 24, 2025

Background Melatonin protects against ischaemic stroke in diabetic animal models, though the mechanisms involving brain and peripheral immune responses remain underexplored. We aimed to clarify how melatonin interacts with these protect mice. Methods Type 1 diabetes mellitus (T1DM) was induced mice using streptozotocin. RNA sequencing of tissue blood mononuclear cells (PBMCs) performed 24 hours poststroke. Inflammatory were evaluated 72 after ischaemia/reperfusion. Results reduced infarction improved neurological function T1DM In brain, downregulated inflammatory factor expression, bioinformatics identifying 62 differentially expressed genes (DEGs) related inflammation 11 associated inflammasomes. Western blotting confirmed reductions NLRP3, HMGB1 Cleaved Caspase-1 expression. Flow cytometry showed infiltration CD8+T neutrophils. decreased IL-6, IL-1β IL-4 levels. PBMCs, revealed 939 DEGs following treatment. Kyoto Encyclopaedia Genes Genomes analysis indicated that involved metabolic pathways, upregulated enriched Jak-STAT signalling pathway. GO cytosol, macromolecule modification. Protein–protein interaction affected 38 inflammation-associated linked key cytokines (Il6, Il1b, Ifng, Il4). increased cells, monocytes neutrophils blood, suggesting a reversal immunosuppression. Multiplex cytokine assays IL-6 IFN-γ Conclusion Poststroke therapy reduces damage by modulating central responses.

Language: Английский

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging DOI Creative Commons
Klaudia Jomová,

Renáta Raptová,

Suliman Yousef Alomar

et al.

Archives of Toxicology, Journal Year: 2023, Volume and Issue: 97(10), P. 2499 - 2574

Published: Aug. 19, 2023

Abstract A physiological level of oxygen/nitrogen free radicals and non-radical reactive species (collectively known as ROS/RNS) is termed oxidative eustress or “good stress” characterized by low to mild levels oxidants involved in the regulation various biochemical transformations such carboxylation, hydroxylation, peroxidation, modulation signal transduction pathways Nuclear factor-κB (NF-κB), Mitogen-activated protein kinase (MAPK) cascade, phosphoinositide-3-kinase, nuclear factor erythroid 2–related 2 (Nrf2) other processes. Increased ROS/RNS, generated from both endogenous (mitochondria, NADPH oxidases) and/or exogenous sources (radiation, certain drugs, foods, cigarette smoking, pollution) result a harmful condition stress (“bad stress”). Although it widely accepted, that many chronic diseases are multifactorial origin, they share common denominator. Here we review importance mechanisms through which contributes pathological states an organism. Attention focused on chemistry ROS RNS (e.g. superoxide radical, hydrogen peroxide, hydroxyl radicals, peroxyl nitric oxide, peroxynitrite), their role damage DNA, proteins, membrane lipids. Quantitative qualitative assessment biomarkers also discussed. Oxidative pathology cancer, cardiovascular diseases, diabetes, neurological disorders (Alzheimer’s Parkinson’s Down syndrome), psychiatric (depression, schizophrenia, bipolar disorder), renal disease, lung disease (chronic pulmonary obstruction, cancer), aging. The concerted action antioxidants ameliorate effect achieved antioxidant enzymes (Superoxide dismutases-SODs, catalase, glutathione peroxidase-GPx), small molecular weight (vitamins C E, flavonoids, carotenoids, melatonin, ergothioneine, others). Perhaps one most effective vitamin first line defense against peroxidation promising approach appears be use flavonoids), showing weak prooxidant properties may boost cellular systems thus act preventive anticancer agents. Redox metal-based enzyme mimetic compounds potential pharmaceutical interventions sirtuins therapeutic targets for age-related anti-aging strategies

Language: Английский

Citations

923

Signaling pathways and targeted therapy for myocardial infarction DOI Creative Commons
Qing Zhang, Lu Wang, Shiqi Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: March 10, 2022

Abstract Although the treatment of myocardial infarction (MI) has improved considerably, it is still a worldwide disease with high morbidity and mortality. Whilst there long way to go for discovering ideal treatments, therapeutic strategies committed cardioprotection cardiac repair following ischemia are emerging. Evidence pathological characteristics in MI illustrates cell signaling pathways that participate survival, proliferation, apoptosis, autophagy cardiomyocytes, endothelial cells, fibroblasts, monocytes, stem cells. These include key players inflammation response, e.g., NLRP3/caspase-1 TLR4/MyD88/NF-κB; crucial mediators oxidative stress instance, Notch, Hippo/YAP, RhoA/ROCK, Nrf2/HO-1, Sonic hedgehog; controller fibrosis such as TGF-β/SMADs Wnt/β-catenin; main regulator angiogenesis, PI3K/Akt, MAPK, JAK/STAT, hedgehog, etc. Since play an important role administering process MI, aiming at targeting these aberrant improving manifestations indispensable promising. Hence, drug therapy, gene protein exosome therapy have been emerging known novel therapies. In this review, we summarize by regulating associated pathways, which contribute inhibiting cardiomyocytes death, attenuating inflammation, enhancing so re-functionalize damaged hearts.

Language: Английский

Citations

468

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression DOI Creative Commons
Jesús Beltrán-García, Rebeca Osca-Verdegal, Federico V. Pallardó

et al.

Antioxidants, Journal Year: 2020, Volume and Issue: 9(10), P. 936 - 936

Published: Sept. 29, 2020

Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak emerged, countless efforts are being made worldwide to understand molecular mechanisms underlying disease 2019 (COVID-19) in an attempt identify specific clinical characteristics of critically ill COVID-19 patients involved its pathogenesis and provide therapeutic alternatives minimize severity. Recently, has been closely related sepsis, which suggests that most deceases intensive care units (ICU) may be a direct consequence SARS-CoV-2 infection-induced sepsis. Understanding oxidative stress inflammation contributing progression phenotypes such as sepsis is current need effort improve therapies infected patients. This article aims review relationship with inflammation, can contribute progression. We also overview potential antioxidant active trials might prevent or reduce

Language: Английский

Citations

141

Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements DOI Open Access
Deanna M. Minich,

Melanie Henning,

Catherine Darley

et al.

Nutrients, Journal Year: 2022, Volume and Issue: 14(19), P. 3934 - 3934

Published: Sept. 22, 2022

Melatonin has become a popular dietary supplement, most known as chronobiotic, and for establishing healthy sleep. Research over the last decade into cancer, Alzheimer’s disease, multiple sclerosis, fertility, PCOS, many other conditions, combined with COVID-19 pandemic, led to greater awareness of melatonin because its ability act potent antioxidant, immune-active agent, mitochondrial regulator. There are distinct similarities between vitamin D in depth breadth their impact on health. Both hormones, affect systems through immune-modulating, anti-inflammatory functions, found skin, responsive sunlight darkness. In fact, there may be widespread concern about deficiency “sunlight deficiency” reduced secretion result “darkness from overexposure artificial blue light. The trend toward use supplements resulted safety, especially higher doses, long-term use, application certain populations (e.g., children). This review aims evaluate recent data melatonin’s mechanisms, clinical uses beyond sleep, safety concerns, thorough summary therapeutic considerations concerning supplementation, including different formats available (animal, synthetic, phytomelatonin), dosing, timing, contraindications, nutrient combinations.

Language: Английский

Citations

88

Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis DOI
Jia‐Ying Kang, Mengmeng Xu, Ying Sun

et al.

International Immunopharmacology, Journal Year: 2022, Volume and Issue: 109, P. 108782 - 108782

Published: April 23, 2022

Language: Английский

Citations

84

Melatonin: the placental antioxidant and anti-inflammatory DOI Creative Commons

Tyana T. Joseph,

Viviane Schuch,

Daniel J. Hossack

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Feb. 1, 2024

Melatonin (N-acetyl-5-methoxytryptamine) is an indolamine hormone with many physiological and biological roles. antioxidant, anti-inflammatory, free radical scavenger, circadian rhythm regulator, sleep hormone. However, its most popular role the ability to regulate through rhythm. Interestingly, recent studies have shown that melatonin important essential during pregnancy, specifically in placenta. This primarily due placenta’s synthesize own rather than depending on pineal gland. During acts as antioxidant which necessary ensure a stable environment for both mother fetus. It placenta because it reduces oxidative stress by constantly scavenging radicals, i.e., maintain integrity. In healthy maternal immune system altered accommodate needs of growing fetus, key anti-inflammatory regulating homeostasis early late gestation. literature review aims identify summarize melatonin’s powerful inflammation favorable homeostatic throughout

Language: Английский

Citations

26

Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice DOI

Ahmed Wahhab Mohammed Khafaji,

Adeeb Ahmed Al-Zubaidy,

Iqbal Farhood

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: 397(8), P. 6231 - 6248

Published: March 6, 2024

Language: Английский

Citations

16

A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19 DOI Open Access

M. R. S. Hawkins,

Sanjeev Sockalingam, Sarah Bonato

et al.

Journal of Psychosomatic Research, Journal Year: 2020, Volume and Issue: 141, P. 110350 - 110350

Published: Dec. 25, 2020

Language: Английский

Citations

76

COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review DOI Creative Commons
Tissa Wijeratne, Sheila G. Crewther, Carmela Sales

et al.

Frontiers in Neurology, Journal Year: 2021, Volume and Issue: 11

Published: Jan. 28, 2021

Clinical reports of neurological manifestations associated with severe coronavirus disease 2019 (COVID-19), such as acute ischemic stroke (AIS), encephalopathy, seizures, headaches, necrotizing encephalitis, cerebral microbleeds, posterior reversible leukoencephalopathy syndrome, hemophagocytic lymphohistiocytosis, peripheral neuropathy, cranial nerve palsies, transverse myelitis, and demyelinating disorders, are increasing rapidly. However, there comparatively few studies investigating the potential impact immunological responses secondary to hypoxia, oxidative stress, excessive platelet-induced aggregation on brain. This scoping review has focused pathophysiological mechanisms consequential neural (central) inflammation leading COVID-19-related strokes. It also highlights common biological processes shared between AIS COVID-19 infection importance recognition that respiratory dysfunction impairments COVID chronic [post-COVID-19 syndrome (PCNS)] may significantly recovery ability benefit from neurorehabilitation. study provides a comprehensive pathobiology stroke. affirms contribution pathophysiology is predictive sequelae particularly stroke, which makes it expectation rather than exception. work fundamental significance neurorehabilitation community given number COVID-related strokes, current limited knowledge regarding risk reinfection, recent PCNS. further need for global collaboration research into new pathobiology-based treatment strategies more integrated evidence-based care.

Language: Английский

Citations

66

New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy DOI Creative Commons
Suresh Victor, Eridan Rocha‐Ferreira, Ahad A. Rahim

et al.

European Journal of Pediatrics, Journal Year: 2021, Volume and Issue: 181(3), P. 875 - 887

Published: Nov. 24, 2021

Abstract Around 0.75 million babies worldwide suffer from moderate or severe hypoxic-ischemic encephalopathy (HIE) each year resulting in around 400,000 with neurodevelopmental impairment. In 2010, neonatal HIE was associated 2.4% of the total Global Burden Disease. Therapeutic hypothermia (TH), a treatment that is now standard care high-income countries, provides proof concept strategies aim to improve neurodevelopment are not only possible but can also be implemented clinical practice. While TH beneficial, neonates treated still experience devastating complications: 48% (range: 44–53) combined death moderate/severe disability. There concern may effective low- and middle-income countries. Therapies further outcomes desperately needed, they must tested conjunction TH. We have this review focussed on pharmacological options (e.g. erythropoietin, allopurinol, melatonin, cannabidiol, exendin-4/exenatide). Erythropoietin allopurinol show promise progressing towards clinic ongoing definitive phase 3 randomised placebo-controlled trials. However, there remain global challenges for next decade. Conclusion : need more optimal animal models, greater industry support/sponsorship, increased use juvenile toxicology, dose-ranging studies pharmacokinetic-pharmacodynamic modelling, well-designed trials avoid exposure harmful medications abandoning putative treatments. What Known: • beneficial encephalopathy. Neonates therapeutic sequelae. New: Erythropoietin, exendin-4/exenatide hypothermia.

Language: Английский

Citations

66